COLL β€” COLLEGIUM PHARMACEUTICAL INC

Ownership history in CAXTON ASSOCIATES LP  Β·  3 quarters on record

This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in COLLEGIUM PHARMACEUTICAL INC (COLL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.11% (2024 Q3)
πŸ“Š Avg. % of fund
0.09%
πŸ“… First filed
2024 Q1
πŸ“… Last filed
2024 Q3
⏱ Quarters held
3
% of Fund (quarterly)    COLL price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 ADDED 79,344 +25,733 +48.0% 0.11% $3.1M $38.64
2024 Q2 ADDED 53,611 +9,046 +20.3% 0.06% $1.7M $32.20
2024 Q1 INITIATED 44,565 β€” β€” 0.10% $1.7M β€”

🏒 Other funds also holding COLL

As of 2025 Q4 β€” sorted by position size

Ballast Asset Management, LP 2.42% THIRD AVENUE MANAGEMENT LLC 3Y 7Y 1.71% Uniplan Investment Counsel, Inc. 3Y 7Y 1.39% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 1.36% EMERALD ADVISERS, LLC 3Y 7Y 0.9% Rubric Capital Management LP 3Y 7Y 0.83% SummerHaven Investment Management, LLC 3Y 0.68% Jackson Creek Investment Advisors LLC 3Y 0.53% Watershed Asset Management, L.L.C. 3Y 7Y 0.42% Values First Advisors, Inc. 3Y 0.41%
← Back to CAXTON ASSOCIATES LP Holdings